James Liu - Oct 10, 2023 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Sr Dir Controller PAO Int PFO
Signature
/s/ James Liu
Stock symbol
OCX
Transactions as of
Oct 10, 2023
Transactions value $
$0
Form type
4
Date filed
10/12/2023, 04:30 PM
Previous filing
Jan 19, 2023
Next filing
May 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Option to Purchase Common Stock Award $0 +8.48K $0.00 8.48K Oct 10, 2023 Common Stock 8.48K $3.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.